Chemotherapy-Induced Peripheral Neuropathy: Prevention and Treatment (Q37911252)

25 August 2017

1 reference

title

Chemotherapy-induced peripheral neuropathy: prevention and treatment (English)

1 reference

25 August 2017

Chemotherapy-Induced Peripheral Neuropathy: Prevention and Treatment (English)

1 reference

DOI

10.1038/CLPT.2011.115

https://api.crossref.org/works/10.1038/CLPT.2011.115

8 December 2024

1 reference

peripheral neuropathy

1 reference

Chemotherapy-induced peripheral neuropathy

inferred from title

1 reference

D. R. Pachman

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21814197

8 December 2024

D. L. Barton

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21814197

8 December 2024

J. C. Watson

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21814197

8 December 2024

C. L. Loprinzi

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21814197

8 December 2024

language of work or name

English

0 references

publication date

3 August 2011

1 reference

Clinical Pharmacology & Therapeutics

25 August 2017

published in

1 reference

25 August 2017

volume

90

1 reference

25 August 2017

issue

3

1 reference

25 August 2017

page(s)

377-387

1 reference

Chemotherapy-induced neuropathy

25 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.115

Neuropathic pain: diagnosis, pathophysiological mechanisms, and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.115

The Paclitaxel acute pain syndrome: sensitization of nociceptors as the putative mechanism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.115

An evolving cellular pathology occurs in dorsal root ganglia, peripheral nerve and spinal cord following intravenous administration of paclitaxel in the rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.115

Natural History of Paclitaxel-Associated Acute Pain Syndrome: Prospective Cohort Study NCCTG N08C1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.115

Intravenous Calcium and Magnesium for Oxaliplatin-Induced Sensory Neurotoxicity in Adjuvant Colon Cancer: NCCTG N04C7

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.115

Prevention of oxaliplatin-related neurotoxicity by calcium and magnesium infusions: a retrospective study of 161 patients receiving oxaliplatin combined with 5-Fluorouracil and leucovorin for advanced colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.115

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.115

Glutathione reduces the toxicity and improves quality of life of women diagnosed with ovarian cancer treated with cisplatin: results of a double-blind, randomised trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.115

Administration of reduced glutathione in FOLFOX4 adjuvant treatment for colorectal cancer: effect on oxaliplatin pharmacokinetics, Pt-DNA adduct formation, and neurotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.115

N-acetylcysteine has neuroprotective effects against oxaliplatin-based adjuvant chemotherapy in colon cancer patients: preliminary data

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.115

Glutamine as a neuroprotective agent in high-dose paclitaxel-induced peripheral neuropathy: a clinical and electrophysiologic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.115

Acute oxaliplatin-induced peripheral nerve hyperexcitability

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.115

Neuroprotective effect of vitamin E supplementation in patients treated with cisplatin chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.115

Vitamin E neuroprotection for cisplatin neuropathy: a randomized, placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.115

Vitamin E for prophylaxis against chemotherapy-induced neuropathy: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.115

Cellular and functional evidence for a protective action of neurosteroids against vincristine chemotherapy-induced painful neuropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.115

Interleukin-6 protects against paclitaxel, cisplatin and vincristine-induced neuropathies without impairing chemotherapeutic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.115

Topical 2% amitriptyline and 1% ketamine in neuropathic pain syndromes: a randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.115

A double-blind, placebo-controlled trial of a topical treatment for chemotherapy-induced peripheral neuropathy: NCCTG trial N06CA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.115

Evidence for an antihyperalgesic effect of venlafaxine in vincristine-induced neuropathy in rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.115

Venlafaxine extended release in the treatment of painful diabetic neuropathy: a double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.115

Clinical activity of venlafaxine and topiramate against oxaliplatin-induced disabling permanent neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.115

Duloxetine for painful diabetic neuropathy and fibromyalgia pain: systematic review of randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.115

Efficacy of gabapentin in the management of chemotherapy-induced peripheral neuropathy: a phase 3 randomized, double-blind, placebo-controlled, crossover trial (N00C3).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.115

Thioctic acid for patients with symptomatic diabetic polyneuropathy: a critical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.115

Amelioration of docetaxel/cisplatin induced polyneuropathy by alpha-lipoic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.115

Effective treatment of oxaliplatin-induced cumulative polyneuropathy with alpha-lipoic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.115

Acetyl-L-carnitine in neuropathic pain: experimental data.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.115

Pharmacological treatment of painful HIV-associated sensory neuropathy: a systematic review and meta-analysis of randomised controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.115

Acetyl-L-carnitine prevents and reduces paclitaxel-induced painful peripheral neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.115

Symptomatic and neurophysiological responses of paclitaxel- or cisplatin-induced neuropathy to oral acetyl-L-carnitine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.115

Prevention of paclitaxel-evoked painful peripheral neuropathy by acetyl-L-carnitine: effects on axonal mitochondria, sensory nerve fiber terminal arbors, and cutaneous Langerhans cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.115

Phase III evaluation of nortriptyline for alleviation of symptoms of cis-platinum-induced peripheral neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.115

Amitriptyline in the treatment of chemotherapy-induced neuropathic symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.115

Efficacy of lamotrigine in the management of chemotherapy-induced peripheral neuropathy: a phase 3 randomized, double-blind, placebo-controlled trial, N01C3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.115

EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.115

Mexiletine reverses oxaliplatin-induced neuropathic pain in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.115

Spinal cord and peripheral nerve stimulation techniques for neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.115

Spinal cord stimulation relieves chemotherapy-induced pain: a clinical case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.115

Pilot trial of a patient-specific cutaneous electrostimulation device (MC5-A Calmare®) for chemotherapy-induced peripheral neuropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.115

Electrotherapy for the treatment of painful diabetic peripheral neuropathy: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.115

Integrating patient-reported outcomes into cancer symptom management clinical trials supported by the National Cancer Institute-sponsored clinical trials networks

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.115

Psychometric evaluation of the Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity (Fact/GOG-Ntx) questionnaire for patients receiving systemic chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.115

Measuring the side effects of taxane therapy in oncology: the functional assesment of cancer therapy-taxane (FACT-taxane).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.115

Transient Receptor Potential Vanilloid 1 is essential for cisplatin-induced heat hyperalgesia in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.115

Genetic factors underlying the risk of thalidomide-related neuropathy in patients with multiple myeloma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.115

Mechanisms of peripheral neuropathy associated with bortezomib and vincristine in patients with newly diagnosed multiple myeloma: a prospective analysis of data from the HOVON-65/GMMG-HD4 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.115

Weekly cisplatin +- glutathione in relapsed ovarian carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.115

Protective Effect of Erythropoietin and Its Carbamylated Derivative in Experimental Cisplatin Peripheral Neurotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.115

The Total Neuropathy Score as an assessment tool for grading the course of chemotherapy-induced peripheral neurotoxicity: comparison with the National Cancer Institute-Common Toxicity Scale

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.115

Use of calcium and magnesium salts to reduce oxaliplatin-related neurotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.115

7 January 2021

Oral glutamine is effective for preventing oxaliplatin-induced neuropathy in colorectal cancer patients

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.115

7 January 2021

Efficacy of oxcarbazepine for prophylaxis against cumulative oxaliplatin-induced neuropathy

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.115

7 January 2021

Preventing paclitaxel-induced peripheral neuropathy: a phase II trial of vitamin E supplementation

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.115

7 January 2021

Erythropoietin against cisplatin-induced peripheral neurotoxicity in rats

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.115

7 January 2021

Gastrosplenic fistula from Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.115

7 January 2021

Effect of mexiletine on vincristine-induced painful neuropathy in mice

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.115

7 January 2021

Acupuncture treatment for chemotherapy-induced peripheral neuropathy--a case series

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.115

7 January 2021

The development of an EORTC quality of life questionnaire to assess chemotherapy-induced peripheral neuropathy: the QLQ-CIPN20

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2011.115

7 January 2021

Identifiers

DOI

10.1038/CLPT.2011.115

1 reference

Dimensions Publication ID

25 August 2017

1025189218

0 references

1 reference